TG2-33240-83559
3 vaccinations
2 coded responses
27 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 917 / CA
- Registered
- 2022-08-05
- Relationship
- Child or adolescent in my care
- Guardian
- 8SF-17857-87013
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-21
Dose 1 — Pfizer-BioNTech
-
2022-08-05
Registered in v-safe
- 2022-08-05
-
2022-08-11
Dose 2 — Pfizer-BioNTech
-
2022-08-12
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
-
2022-08-13
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-08-14
- 2022-08-15
- 2022-08-16
-
2022-08-17
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Fever · Be unable to work or attend schoolFree text: Cough and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-08-18
Survey response — day 7, dose 2, under 3MedDRA: Eye pruritus, Lacrimation increased — Feeling: Fair · Fever · Loss of appetite · Be unable to work or attend schoolFree text: Itchy, watery eyesMedDRA releases: 2024-11 · check-in free text available
- 2022-08-26
- 2022-09-01
- 2022-09-08
- 2022-09-17
- 2022-09-24
-
2022-10-12
Dose 3 — Pfizer-BioNTech
- 2022-10-12
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2023-01-11
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-21 | Pfizer-BioNTech | No |
| 2 | 2022-08-11 | Pfizer-BioNTech | No |
| 3 | 2022-10-12 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Cough and runny nose
Release 12 (Under 3) — day 7, dose 2, under 3
Systemic reaction (other): Itchy, watery eyes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
| SRO | Eye pruritus | · | · | ✓ |
| SRO | Lacrimation increased | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release